Abstract

Objective To observe the effect of berberine (BBR) on kidney cell pyroptosis in golden hamsters with diabetic nephropathy (DN) and to explore the molecular mechanism of its renal protection. Methods Fifty clean-grade male golden hamsters were randomly divided into a control group (10) and a model building group (40). The DN model was established by high-sugar and high-fat feeding and injection of a small amount of STZ. After successful establishment of the model, they were randomly divided into a model group, western medicine group, and berberine high- and low-dose groups. The western medicine group was given irbesartan 13.5 mg/kg, and the berberine high- and low-dose groups were given BBR 200 mg/kg and 100 mg/kg, respectively, for 8 consecutive weeks. An automatic biochemical analyser was used to measure blood glucose, blood lipids, kidney function, MDA, and other indicators; radioimmunoassay was used to assess serum insulin; enzyme-linked immunosorbent assay (ELISA) was used to quantify IL-1β, IL-6, IL-18, TNF-α; HE, PAS, and Masson staining were used to observe kidney pathological tissue morphology; western blot and real-time fluorescent quantitative PCR were used to assess protein and mRNA expression of molecules, such as Nrf2, NLRP3, Caspase-1, and GSDMD; and TUNEL staining was used to detect DNA damage. SPSS statistical software was used for the data analysis. Results The kidney tissues of golden hamsters in the control group were normal; Nrf2 was highly expressed, serum MDA level was low, NLRP3 expression in kidney tissue was not obvious, Caspase-1 and GSDMD were weakly expressed, and only a few TUNEL-positive cells were observed. Compared with the control group, the golden hamsters in the model group had obvious renal pathological damage; blood glucose, blood lipids, renal function-related indexes, insulin, and inflammatory factors IL-1β, IL-6, IL-18, and TNF-α were increased (P < 0.05); NLRP3, Caspase-1, and GSDMD expression was increased; Nrf2 expression was decreased; MDA level was increased (P < 0.05); and the number of TUNEL-positive cells was increased. Compared with the model group, the pathological morphology of the kidney tissue of golden hamsters in the three treatment groups was significantly improved; blood glucose, blood lipids, renal function, and the expression of inflammatory factors IL-1β and IL-6 were reduced (P < 0.05); NLRP3, Caspase-1, GSDMD, and other molecular proteins and mRNA expression were decreased; Nrf2 expression was increased; MDA level was decreased (P < 0.05); and the number of TUNEL-positive cells was decreased. Conclusion DN golden hamster kidney NLRP3-Caspase-1-GSDMD signalling was enhanced. BBR can reduce oxidative stress damage by regulating antioxidative Nrf2 and then regulating NLRP3-Caspase-1-GSDMD signalling to inhibit pyroptosis, antagonizing DN inflammation-induced damage.

Highlights

  • Diabetic nephropathy (DN) accounts for 30% to 50% of endstage renal disease (ESRD) cases and has become a public problem that seriously threatens the health of people worldwide [1]

  • The golden hamsters in the control group were generally in good condition, with normal diet, drinking water and urine output, good mental condition, and neat and shiny hair. e golden hamsters in the model group showed dull coats, increased food intake, sluggish movement, polydipsia, and polyuria. e abovementioned symptoms of golden hamsters in the three treatment groups were improved to varying degrees compared with the model group

  • Comparison of Blood Glucose and Blood Lipids of Golden Hamsters in Each Group. Compared with those in the control group, the GLU, total cholesterol (TC), TG, and LDL-C levels of golden hamsters were increased in the model group (P < 0.05)

Read more

Summary

Introduction

Diabetic nephropathy (DN) accounts for 30% to 50% of endstage renal disease (ESRD) cases and has become a public problem that seriously threatens the health of people worldwide [1]. Pyroptosis is a recently discovered mode of programmed cell death accompanied by inflammation [4], a renal complication associated with hyperglycaemia, inflammation, and oxidative stress [5]. An important mechanism of inflammation is the induction of inflammasomes, which activate cysteinyl aspartate specific proteinase-1 (Caspase-1) and process inflammatory cytokines to cause pyroptosis. E NOD-like receptor protein 3 (NLRP3) inflammasome-mediated NLRP3-Caspase-1-GSDMD canonical pyroptosis pathway is an important mechanism of DN renal cell inflammatory damage [10]. Berberine (BBR) is an isoquinoline alkaloid mainly isolated from Coptis and Phellodendron It has antiinflammatory, antioxidant, hypoglycaemic, hypolipidaemic, and other pharmacological activities [11]. Previous studies have shown that BBR can delay the progression of DN by regulating related inflammatory factors and signalling pathways [12], but its exact mechanism has not been fully elucidated. Does BBR affect renal cell pyroptosis? Can BBR inhibit cells by regulating the oxidative stress regulator Nrf2?

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call